Patents Assigned to Geneprint Corporation
  • TREM-1 splice variant for use in modifying immune responses
    Patent number: 8114603
    Abstract: The present invention relates to a soluble receptor variant of TREM-1. More particularly, present invention relates to methods of modulating an immune response by administering variants of TREM-1.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: February 14, 2012
    Assignee: Geneprint Corporation
    Inventors: Judith F. Margolin, Marie-Claude Gingras
  • TREM-1 splice variant for use in modifying immune responses
    Patent number: 7858094
    Abstract: The present invention relates to a soluble receptor variant of TREM-1. More particularly, present invention relates to methods of modulating an immune response by administering variants of TREM-1.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: December 28, 2010
    Assignee: Geneprint Corporation
    Inventors: Judith F. Margolin, Marie-Claude Gingras